G Renoux - Pharmacology & Therapeutics. Part A: Chemotherapy …, 1978 - Elsevier
The clinical need for therapeutic agents designed to augment immune responsiveness in patients with deficient or depressed resistance has led to an increased interest in cellular …
The need for treatments to correct an immunological defect, or to restore an impaired immune response associated with disease or ageing, has led to the development of …
The immunopotentiating drug, levamisole, was found to augment human lymphocyte responses to allogeneic cells and plant mitogens in vitro. The effect was critically dose …
H Verhaegen, J Cree, W Cock, F Verbruggen - 1973 - cabidigitallibrary.org
Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …
Levamisole, an immunopotentiator, was compared to its parent molecule imidazole in its effects on lymphocyte proliferation and cyclic nucleotide levels. Both levamisole and …
N Scheinfeld, JD Rosenberg, JM Weinberg - American journal of clinical …, 2004 - Springer
Levamisole, an anthelmintic agent with a wide range of immunomodulatory actions, has been used successfully as monotherapy and an adjunct to treatment in a variety of diseases …
MS Sajid, Z Iqbal, G Muhammad, MU Iqbal - Parasitology, 2006 - cambridge.org
This paper reviews the immunomodulatory effects (immunosuppression or immunoactivation) of various anthelmintics including levamisole, fenvalerate, dieldrin …
G Renoux, M RENOUX - Nature New Biology, 1972 - nature.com
WE have reported the stimulatory effects of racemic 2, 3, 5, 6-tetrahydro-6-phenyl-imidazo (2, 1,-b) thiazole,“tetramisole” and of its l-isomer,“levamisole”, on antibacterial …
G Renoux, M Renoux - The Journal of Immunology, 1974 - journals.aai.org
Two phenylimidothiazole salts, racemic tetramisole and l-isomer, levamisole, modulate mouse immune responsiveness. They produce either enhancement or depression of the …